Close Menu

NEW YORK – Shares of Exact Sciences rose more than 27 percent Thursday after the company presented new data at an investor conference on a pan-cancer liquid biopsy test that it's developing in partnership with the Mayo Clinic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.